Amoxicillin And Clavulanate Potassium For Suspension
Product Images NDC 42571-395

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Amoxicillin And Clavulanate Potassium (NDC 42571-395). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Micro Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Amoxi-lbel.jpg (Amoxi Lbel)

This text provides directions for mixing Amoxicillin and Clavulanate Potassium oral suspension. It includes instructions on reconstitution, dosage, storage, and expiration after reconstitution. The suspension contains 600 mg of Amoxicillin and 42.9 mg of Clavulanic Acid per 5 mL. It also alerts about the presence of phenylalanine. The reconstituted suspension should be refrigerated and discarded after 10 days.*

FDA Label Image

Amoxi-strua.jpg (Amoxi Strua)

FDA Label Image

Amoxi-strub.jpg (Amoxi Strub)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.